SCHEMBL6940893

SCHEMBL6940893

C[C@H](OCc1ccccc1)[C@@H](O)CCO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RCE1 Q9Y256 1/20 0.48
HTT P42858 3/20 0.45
MMP9 P14780 2/20 0.41
MMP8 P22894 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 2/20 0.40
TRPA1 O75762 3/20 0.40
MAPT P10636 1/20 0.39
SLC1A3 P43003 2/20 0.39
SLC1A2 P43004 2/20 0.39
SLC1A1 P43005 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173226 0.86 RCE1 (0.48) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL995692 0.86 KMT2A (0.42) RCE1HTTALDH1A1LMNAHPGD
SCHEMBL11961367 0.86 RCE1 (0.50) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL16265939 0.86 RCE1 (0.50) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL11961366 0.86 RCE1 (0.50) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL1487082 0.86 RCE1 (0.50) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL11961365 0.86 RCE1 (0.50) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL11961368 0.86 RCE1 (0.50) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL19088657 0.84 RCE1 (0.46) RCE1HTTMMP9MMP8ALDH1A1
SCHEMBL6173347 0.83 RCE1 (0.49) RCE1HTTMMP9MMP8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed